Covenant Multifamily Offices’s Quest Diagnostics DGX Stock Holding History

Covenant Multifamily Offices’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$229K	Buy	+1,622	New	+$237K	0.04%	214

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Covenant Multifamily Offices's DGX Position: Q3 2021 in Review

Covenant Multifamily Offices opened a new position in Quest Diagnostics (DGX) in Q3 2021: 1,622 shares worth $229K. The stake represents 0.04% of the portfolio and ranks #214 among its holdings.

838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

Covenant Multifamily Offices held 1,622 shares of Quest Diagnostics worth $229K as of Q3 2021.
Quest Diagnostics was a new Covenant Multifamily Offices position in Q3 2021.
Quest Diagnostics made up 0.04% of Covenant Multifamily Offices's portfolio in Q3 2021, its #214 holding.
838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.